Outcomes toolbox for head and neck cancer research

Jolie Ringash*, Lori J. Bernstein, David Cella, Jerilynn Logemann, Benjamin Movsas, Barbara Murphy, Andrea Trotti, Nancy Wells, Bevan Yueh, John Ridge

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Abstract

Background. Clinical research in head and neck cancer traditionally focused on tumor control. As survival improves, it is increasingly recognized that the side-effects of multimodality treatment can be profound and enduring. Thus, clinical trials require patient-reported and functional outcomes. Methods. A subcommittee of the Previously Untreated, Locally Advanced (PULA) Task Force of the Head and Neck Steering Committee of the Coordinating Centre for Clinical Trials at the National Cancer Institute (NCI) was convened to identify a set of instruments suitable for widespread application in the conduct of clinical trials for head and neck cancer. Results. Based on existing literature and expert opinion, 18 main areas of concern were identified. For each, measures suitable for use in multicenter clinical trials were recommended on the basis of validity, feasibility, and clinical acceptance. Conclusion. Suitable instruments exist for most head and neck cancer concerns, but gaps require further development. Future efforts should be made to harmonize measurement across trials.

Original languageEnglish (US)
Pages (from-to)425-439
Number of pages15
JournalHead and Neck
Volume37
Issue number3
DOIs
StatePublished - Mar 1 2015

Keywords

  • Clinical trials
  • Head and neck neoplasms
  • Outcomes
  • Quality of life
  • Questionnaires

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Outcomes toolbox for head and neck cancer research'. Together they form a unique fingerprint.

Cite this